Skip to content

Effect of Validation therapy on Quality of life and Cognitive status

Comparison of Validation therapy in the Quality of life and Cognitive status in Alzheimer-type Dementia subjects in intervention group with control group without intervention(A clinical trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014102819726N1
Enrollment
Unknown
Registered
2015-12-03
Start date
2014-09-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer-type Dementia. Dementia in Alzheimer's disease

Interventions

Intervention 1: Intervention2: in control group, was not done any intervention. Intervention 2: Intervention 1: members of the experimental group was exposed to 36 sessions of the individual Valida
Rephrasing and repeating their key word, picking up their tempo, reflecting the look in their eyes, listening their verbs, using their preferred verbs, speaking their language, asking the end and que
Intervention2: in control group, was not done any intervention
Intervention 1: members of the experimental group was exposed to 36 sessions of the individual Validation therapy intervention, during 3 months, 3 days a week, each session lasted from 10 to 1
Rephrasing and repeating their key word, picking up their tempo, reflecting the look in their eyes, listening their verbs, using their preferred verbs,

Sponsors

Vice chancellor for research, University of Social Welfare and Rehabilitation Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Sixty two elderly residents of three Nursing homes on the basis of inclusion criteria: the diagnosis of Alzheimer-type Dementia? residency at least 6 months or longer? 65 to 90 years of age Exclusion criteria: do not have satisfaction to cooperate? the risk of an acute illness

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: Before and immediately after the intervention. Method of measurement: Quality of life (Alzheimer Disease) questionnaire.;Cognitive status. Timepoint: Before and immediately after the intervention. Method of measurement: Clock Drawing Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Hamid Reza Khankeh

University of Social Welfare and Rehabilitation Sciences

hamid.khankeh@ki.se+98 21 2218 0160

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026